Table 1 Clinical characteristics... | American Society of Hematology

Table 1

Clinical characteristics

Clinical characteristics	Hemophilia (n = 18)	Control (n = 36)	P value
Male, n (%)	18 (100)	36 (100)
Age, years	33.5 ± 3.1	33.7 ± 2.2	.961
Height, cm	167.2 ± 6.8	177.6 ± 1.2	.148
Weight, kg	70.7 ± 5.6	78.1 ± 2.2	.160
BMI, kg/m²	26.5 ± 2.4	24.8 ± 0.8	.512
HIV-positive, n (%)	3 (17)
Hemophilia A/B, n (%)	15 (83)/3(17)
Severe/moderate hemophilia, n (%)	15 (83)/3 (17)
Cirrhosis, n (%)	4 (22)
Primary prophylaxis, n (%)	5 (28)
Positive fracture history, n (%)	4 (22)
Vitamin D, nmol/L*	59.1 ± 6.5
Gilbert joint score†	15.7 ± 2.8

Clinical characteristics	Hemophilia (n = 18)	Control (n = 36)	P value
Male, n (%)	18 (100)	36 (100)
Age, years	33.5 ± 3.1	33.7 ± 2.2	.961
Height, cm	167.2 ± 6.8	177.6 ± 1.2	.148
Weight, kg	70.7 ± 5.6	78.1 ± 2.2	.160
BMI, kg/m²	26.5 ± 2.4	24.8 ± 0.8	.512
HIV-positive, n (%)	3 (17)
Hemophilia A/B, n (%)	15 (83)/3(17)
Severe/moderate hemophilia, n (%)	15 (83)/3 (17)
Cirrhosis, n (%)	4 (22)
Primary prophylaxis, n (%)	5 (28)
Positive fracture history, n (%)	4 (22)
Vitamin D, nmol/L*	59.1 ± 6.5
Gilbert joint score†	15.7 ± 2.8

Unless otherwise specified, values are presented as percentage or mean ± SE

BMI, body mass index.

Vitamin D levels available in 17 subjects; 7 (41%) vitamin D deficiency (<50 nmol/L).

Gilbert joint score measured in 17 subjects.